Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

0.8998
+0.05876.98%
Post-market: 0.8900-0.0098-1.09%19:31 EDT
Volume:157.77K
Turnover:135.77K
Market Cap:3.49M
PE:-0.09
High:0.8999
Open:0.8200
Low:0.8200
Close:0.8411
52wk High:24.30
52wk Low:0.8200
Shares:3.88M
Float Shares:3.81M
Volume Ratio:1.07
T/O Rate:4.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.13
PE(LYR):-0.06

Loading ...

Mar 06, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 21, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Major Issues Report

Form 8-K - Current report
Feb 10, 2024

Correspondence

Form CORRESP - Correspondence
Feb 10, 2024

Correspondence

Form CORRESP - Correspondence
Feb 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 01, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 21, 2023

Major Issues Report

Form 8-K - Current report
Oct 13, 2023

Major Issues Report

Form 8-K - Current report